title: Carotid artery infusions for pharmacokinetic and pharmacodynamic analysis of taxanes in mice.
abstract: When proposing the use of a drug, drug combination, or drug delivery into a novel system, one must assess the pharmacokinetics of the drug in the study model. As the use of mouse models are often a vital step in preclinical drug discovery and drug development, it is necessary to design a system to introduce drugs into mice in a uniform, reproducible manner. Ideally, the system should permit the collection of blood samples at regular intervals over a set time course. The ability to measure drug concentrations by mass-spectrometry, has allowed investigators to follow the changes in plasma drug levels over time in individual mice. In this study, paclitaxel was introduced into transgenic mice as a continuous arterial infusion over three hours, while blood samples were simultaneously taken by retro-orbital bleeds at set time points. Carotid artery infusions are a potential alternative to jugular vein infusions, when factors such as mammary tumors or other obstructions make jugular infusions impractical. Using this technique, paclitaxel concentrations in plasma and tissue achieved similar levels as compared to jugular infusion. In this tutorial, we will demonstrate how to successfully catheterize the carotid artery by preparing an optimized catheter for the individual mouse model, then show how to insert and secure the catheter into the mouse carotid artery, thread the end of the catheter out through the back of the mouse's neck, and hook the mouse to a pump to deliver a controlled rate of drug influx. Multiple low volume retro-orbital bleeds allow for analysis of plasma drug concentrations over time.
authors.affiliation: Program in Developmental Therapeutics, Fox Chase Cancer Center.
authors.forename: Joely D
authors.initials: JD
authors.lastname: Jacobs
authors.affiliation: Program in Developmental Therapeutics, Fox Chase Cancer Center; Elizabeth.Hopper@fccc.edu.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Hopper-Borge
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D007261:Infusions, Intra-Arterial; D051379:Mice; D008810:Mice, Inbred C57BL; D023421:Models, Animal; D017239:Paclitaxel / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel